Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VIMOVO 20 MG — DIN 02361701

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) : 20 MG NAPROXEN : 375 MG · XEDITON PHARMACEUTICALS INC · TABLET (IMMEDIATE AND DELAYED-RELEASE) · wholesale supply in Canada

Health Canada status: MARKETED

What is VIMOVO?

VIMOVO 20 MG contains ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) : 20 MG NAPROXEN : 375 MG. It is listed in the Health Canada Drug Product Database under DIN 02361701, held by XEDITON PHARMACEUTICALS INC, supplied as TABLET (IMMEDIATE AND DELAYED-RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 28-Feb-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does Naproxen And Esomeprazole cost around the world?

Naproxen And Esomeprazole is listed on 16 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition874USD███.██
South Africasingle exit price1625ZAR███.██
SwedenAIP (pharmacy purchase price)924SEK███.██
Australiaex-manufacturer823AUD███.██
AustriaKVP (Kassenverkaufspreis)816EUR███.██
Saudi Arabiapublic1114SAR███.██
Bahrainretail (max)59BHD███.██
United Arab Emiratespublic56AED███.██
Icelandmax wholesale55ISK███.██
Luxembourgreimbursement55EUR███.██
Czechiamax producer price (ex-factory)24CZK███.██
United Kingdomhospital44GBP███.██
Hungaryproducer price (ex-factory)44HUF███.██
Romaniamax producer price44RON███.██
Greeceproducer price (ex-factory)33EUR███.██
Belgiumpublic22EUR███.██

222 pack listings across 99 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every Naproxen And Esomeprazole pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Naproxen And Esomeprazole in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

2 holders have a Canadian DIN containing Naproxen And Esomeprazole, across 4 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
MYLAN PHARMACEUTICALS ULC22MYLAN-NAPROXEN/ESOMEPRAZOLE MRSourceable in Canada
XEDITON PHARMACEUTICALS INC22VIMOVOSourceable in Canada

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label20 MG
Dosage formTABLET (IMMEDIATE AND DELAYED-RELEASE)
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceNaproxen And Esomeprazole
ATC codeM01AE52
AHFS class28:08.04.92 ; 56:28.36
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02361701
DIN (unpadded, as printed on some documents)2361701
Brand nameVIMOVO
Generic / active ingredientESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) : 20 MG NAPROXEN : 375 MG
Market authorization holderXEDITON PHARMACEUTICALS INC
Health Canada schedulePrescription
ATC codeM01AE52
ATC anatomical main groupM — Musculo-skeletal system
ATC therapeutic subgroupM01AE
Current statusMARKETED
Status date28-Feb-2022
Original market date2011-02-04 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

4 of 4 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
MYLAN-NAPROXEN/ESOMEPRAZOLE MR500 MGTABLET (IMMEDIATE AND DELAYED-RELEASE)MYLAN PHARMACEUTICALS ULCMARKETED02443449
MYLAN-NAPROXEN/ESOMEPRAZOLE MR375 MGTABLET (IMMEDIATE AND DELAYED-RELEASE)MYLAN PHARMACEUTICALS ULCMARKETED02458608
VIMOVO20 MGTABLET (IMMEDIATE AND DELAYED-RELEASE)XEDITON PHARMACEUTICALS INCMARKETED02361728

2 · Same class — other molecules in ATC M01AE

MoleculeCanadian brandsDINsMarketedSourceable
IbuprofenACTIPROFEN - CAPLET 200MG · ADVIL 12 HOUR · ADVIL ARTHRITIS PAIN · ADVIL CAPLETS · +107 more14346Yes
NaproxenALEVE BACK AND BODY PAIN · ALEVE CAPLETS · ALEVE LIQUID GELS · ALEVE NIGHTTIME · +81 more12531Yes
Ibuprofen, CombinationsADVIL COLD & FLU · ADVIL COLD & SINUS CONVENIENCE PACK · ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS · ADVIL COLD & SINUS LIQUI-GELS · +36 more4013Yes
Naproxen And EsomeprazoleMYLAN-NAPROXEN/ESOMEPRAZOLE MR · VIMOVO44Yes
KetoprofenKETOPROFEN · KETOPROFEN SR · KETOPROFEN SUPPOSITORIES · KETOPROFEN-E · +28 more363Yes
Tiaprofenic AcidALBERT TIAFEN SR · ALBERT TIAFEN TAB 200MG · ALBERT TIAFEN TAB 300MG · APO-TIAPROFENIC TABLETS -300MG · +15 more252Yes
FlurbiprofenANSAID TABLETS 100 MG · ANSAID TABLETS 50 MG · FLURBIPROFEN · FLURBIPROFEN-100 TAB 100MG · +12 more192Yes
OxaprozinAPO-OXAPROZIN · DAYPRO · RHOXAL-OXAPROZIN30Not in Canada
FenoprofenNALFON CAP 300MG · NALFON TAB 600MG20Not in Canada
Naproxen And DiphenhydraminePAIN RELIEVER & SLEEP AID10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC M01A

ATC subgroupMoleculesDINsMarketed
M01ABDiclofenac · Diclofenac, Combinations · Etodolac · Indometacin · Ketorolac · +2 more17038
M01AHCelecoxib · Rofecoxib7230
M01ACMeloxicam · Piroxicam · Tenoxicam6714
M01AGMefenamic Acid71
M01AXNabumetone121
M01AAOxyphenbutazone · Phenylbutazone · Phenylbutazone, Combinations70

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is VIMOVO called?

The same molecule, Naproxen And Esomeprazole, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
Naproxen BluefishLatinSweden
Pronaxen®LatinSweden
NapflamLatinSouth Africa
NaprosynLatinAustralia, South Africa
NAROXLatinBahrain
CrysanalLatinAustralia
Naproxen EvolanLatinSweden
Adco-NaproxenLatinSouth Africa
EMOXEN PLUSLatinCzechia
Nafasol EcLatinSouth Africa
NALGESINLatinCzechia
NaprocurLatinSweden
Naprosyn® EnteroLatinSweden
Naproxen OrifarmLatinSweden
Phebra Naproxen SuspensionLatinAustralia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for VIMOVO

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02361701. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.